quinoxalines has been researched along with Sclerosis, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cong, L; Xia, ZK; Yang, RY | 1 |
| Chotani, MA; Daunt, D; Flavahan, NA; Flavahan, S; Mitra, S | 1 |
| Flavahan, NA; Flavahan, S; Liu, Q; Spence, RJ; Tidmore, W; Wiener, CM; Wigley, FM; Wu, S | 1 |
3 other study(ies) available for quinoxalines and Sclerosis, Systemic
| Article | Year |
|---|---|
Targeting the TGF-β receptor with kinase inhibitors for scleroderma therapy.
Topics: Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Molecular Targeted Therapy; Morpholines; Protein Binding; Protein Kinase Inhibitors; Pyrazoles; Quinolines; Quinoxalines; Receptors, Transforming Growth Factor beta; Scleroderma, Systemic | 2014 |
Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arteries; Body Temperature Regulation; Brimonidine Tartrate; Cold Temperature; COS Cells; Imidazoles; Indoles; Isoindoles; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Microcirculation; Muscle, Smooth, Vascular; Organ Culture Techniques; Phenylephrine; Piperazines; Quinolizines; Quinoxalines; Raynaud Disease; Receptors, Adrenergic, alpha-2; Scleroderma, Systemic; Skin; Tail; Vasoconstriction | 2000 |
Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Arterioles; Brimonidine Tartrate; Female; Humans; Male; Middle Aged; Phenylephrine; Quinoxalines; Scleroderma, Systemic; Vasoconstriction; Vasodilator Agents | 2000 |